Effect of melatonin on cholesterol absorption in rats

Journal of Pineal Research

Volumn 42, Issue 3, 2007, Pages 267-271

  Hussain, Saad Abdul Rehman ^a  

^a UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

Cholesterol absorption; Lipoprotein profile; Liver lipids; Melatonin

Indexed keywords

CHOLESTEROL; COLESTYRAMINE; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MELATONIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DRUG INHIBITION; FAT CONTENT; HYPERCHOLESTEROLEMIA; INHIBITION KINETICS; LIPID ABSORPTION; LIPID DIET; LIVER WEIGHT; MALE; NONHUMAN; RAT; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; AZETIDINES; CHOLESTEROL; CHOLESTYRAMINE; INTESTINAL ABSORPTION; LIVER; MALE; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33847687120     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2006.00415.x     Document Type: Article

References (39)

1. STOCKER R, O'HALLORAN RA. Dealcoholized red wine decreases atherosclerosis in apolipoprotein E gene deficient mice independently of inhibition of lipid peroxidation in the artery wall. Am J Clin Nutr 2004; 79:123-130.
2. MARON DJ. Flavonoids for reduction of atherosclerotic risk. Curr Atheroscler Rep 2004; 6:73-78.
3. HUSSAIN SA, HUSSEIN KI, SAIEED BN et al. Improvement of the hypolipidemic effect of lovastatin with melatonin. Iraqi postgrad Med J 2004; 3:343-346.
4. CHAN TY, TANG PL. Effect of melatonin on the maintenance of cholesterol homeostasis in the rat. Endocrine Res 1995; 21:681-696.
5. GIYASETTIN B, OKKES Y, SAIT C et al. Effect of certain micronutrients and melatonin on plasma lipids, lipid peroxidation and homocystein levels in rats. Arch Med Res 2002; 33:515-519.
6. DOMINGUEZ-RODRIGUEZ A, ABREU-GONZALEZ P, GARCIA-GONZALEA M et al. Elevated levels of oxidized low density lipoprotein and impaired nocturnal synthesis in patients with myocardial infarction. Atherosclerosis 2005; 180:101-105.
7. TAN DX, CHEN LD, POEGGELER B et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
8. VANECEK J. Cellular mechanism of melatonin action. Physiol Rev 1998; 78:687-721.
9. REITER RJ, TAN DX, OSUNA C et al. Action of melatonin in the reduction of oxidative stress. J Biochem Sci 2000; 7:444-458.
10. AL-MAHBASHY HM, HUSSAIN SA, NUMAN NM et al. The effects of melatonin on the oxidative stress, protein glycation, microalbuminuria and lipid profile in type 2 diabetes mellitus. Iraqi J Pharm Sci 2006; 15:27-32.
11. ISMAIL SH, HUSSAIN SA, NUMAN NA et al. Hypolipidemic effect of melatonin in dyslipidemia associated with diabetes. Iraqi Postgrad Med J 2004; 3:223-226.
12. MIETTINEN TA. Cholesterol absorption inhibition: a strategy for cholesterol-lowering therapy. Int J Clin Pract 2001; 55:710-716.
13. GOLDSTEIN JL, BROWN MS. Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol. J Lipid Res 1984; 25:1450-1461.
14. TURLEY SD, HERNDON MW, DIETSCHY JM. Re-evaluation and application of the dual-isotope plasma ratio method for the measurement of intestinal cholesterol absorption in the hamster. J Lipid Res 1994; 35:328-339.
15. VAN HEEK M, FARLEY C, COMPTON DS et al. Ezetimibe potently inhibits cholesterol absorption but does not affect acute hepatic or intestinal cholesterol synthesis in rats. Br J Pharmacol 2003; 138:1459-1464.
16. RICHMOND W. Proceeding in the development of an enzymatic technique for the assay of cholesterol in biological fluids. Clin Sci Mol Med 1974; 46:6-7.
17. FOSSATI P, PRENCIPE L. Measurement of serum triglycerides colorimetrically with an enzyme that produce hydrogen peroxide. Clin Chem 1982; 28:2077-2080.
18. HAUG A, HOSTMARK AT. Lipoprotein lipase, lipoproteins and tissue lipids in rats fed fish oil or coconut oil. J Nutr 1987; 117:1011-1017.
19. PAN M, SONG YL, YU JM et al. Melatonin ameliorates nonalcoholic fatty liver induced by high fat diet in rats. J Pineal Res 2006; 41:79-84.
20. KREEMAN V, SKOTTOVA N, WALTEROVA D et al. Silymarin inhibits the development of diet-induced hypercholesterolemia in rats. Planta Med 1998; 64:138-142.
21. SKOTTOVA N, VECERA R et al. Effects of polyphenolic fraction of Silymarin on lipoprotein profile in rats fed cholesterol-rich diet. Pharmacol Res 2003; 47:17-26.
22. CHANG TY, CHANG CC, LIN S, YU C et al. Roles of acylcoenzyme A: cholesterol acyltransferase-1 and -2. Curr Opin Lipidol 2001; 12:289-296.
23. LARGIS EE, WANG CH, DEVRIES VG et al. CL 277,082: a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption. J Lipid Res 1989; 30:681-690.
24. KIM SJ, BOK SH, LEE S et al. Lipid lowering efficacy of 3,4-di(OH)-phenylpropionic l-leucine in high cholesterol fed rats. J Biochem Mol Toxicol 2005; 19:25-31.
25. KITA T, GOLDSTEIN JL, BROWN MS et al. Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor. Proc Natl Acad Sci USA 1982; 79:3623-3627.
26. TURLEY SD. Cholesterol metabolism and therapeutic targets: rationale for targeting multiple metabolic pathways. Clin Cardiol 2004; 27(6 Suppl.3): 16-21.
27. BROWN WV. Cholesterol absorption inhibitors: defining new options in lipid management. Clin Cardiol 2003; 26:259-264.
28. RONNEMAA T. Effect of high cholesterol, olive oil diet on the lipids and connective tissue in rat liver. A biochemical study. Scand J Gastroenterol 1976; 11:849-855.
29. TAHAN V, OZARAS R, CANBAKAN B, UZUN H, AYDIN S, YILDIRIM B et al. Melatonin reduces Dimethylnitrosamineinduced liver fibrosis in rats. J Pineal Res 2004; 37:78-84.
30. SHEN H, HOWLES P, TSO P. From interaction of lipidic vehicles with intestinal epithelial cell membranes to the formation and secretion of chylomicrons. Adv Drug Deliv Rev 2001; 50(Suppl): 103-125.
31. OCKNER RK, HUGHES FB, ISSELBACHER KJ. Very low density lipoproteins in intestinal lymph: role in triglyceride and cholesterol transport during fat absorption. J Clin Invest 1969; 48:2367-2373.
32. PADILLO FJ, CRUZ A, NAARRETE C et al. Melatonin prevents oxidative stress and hepatocyte cell death induced by experimental cholestasis. Free Radic Res 2004; 38:697-704.
33. VAN HEEK M, FARLEY C, COMPTON DS et al. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br J Pharmacol 2001; 134:409-417.
34. DUJOVNE CA, ETTINGER MP, MCNEER JF et al. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol 2002; 90:1092-1097.
35. VAN HEEK M, AUSTIN TM, FARLEY C et al. Ezetimibe, a potent cholesterol absorption inhibitor, normalizes combined dyslipidemia in obese hyperinsulinemic hamsters. Diabetes 2001; 50:1330-1335.
36. GROOT PH, PEARCE NJ, SUCKLING KE et al. Effects of cholestyramine on lipoprotein levels and metabolism in Syrian hamsters. Biochim Biophys Acta 1992; 1123:76-84.
37. KERZNER B, CORBELLI J, SHARP S et al. Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia. Am J Cardiol 2003; 91:418-424.
38. EKSTEDT B, JONSSON E, JOHNSON O. Influence of dietary fat, cholesterol and energy on serum lipids at vigorous physical exercise. J Clin Lab Invest 1991; 51:437-442.
39. RUDEL LL. Genetic factors influence the atherogenic response of lipoproteins to dietary fat and cholesterol in nonhuman primates. J Am Coll Nutr 1997; 16:306-312.